Bluebird Bio reported $15.3M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
Alnylam Pharmaceuticals ALNY:US $ 30.26M 7.23M
Amgen AMGN:US $ 1637M 147M
Biogen BIIB:US $ 459.7M 18.4M
Biomarin Pharmaceutical BMRN:US $ 127.06M 6.9M
Bluebird Bio BLUE:US $ 15.3M 13.02M
Gilead Sciences GILD:US $ 1390M 29M
Intercept Pharmaceuticals ICPT:US $ 0.62M 0.19M
IONIS PHARMACEUT IONS:US $ 2.96M 0.38M
Moderna Inc MRNA:US 750M 557M
Nektar Therapeutics NKTR:US $ 7.67M 1.91M
Novartis NOVN:VX SF 3754M 79M
Pfizer PFE:US $ 6992M 2820M
Ptc Therapeutics PTCT:US $ 7.36M 1.75M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Sarepta Therapeutics SRPT:US $ 19.52M 2.83M
Seattle Genetics SGEN:US $ 78.09M 13.96M
Ultragenyx Pharmaceutical RARE:US $ 3.14M 2.05M
Vertex Pharmaceuticals VRTX:US $ 227.97M 35.64M
YTE INCY:US $ 32.63M 8.81M